FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023694826> ?p ?o ?g. }

• W2023694826 endingPage "215" @default.
• W2023694826 startingPage "206" @default.
• W2023694826 abstract "Ondansetron is primarily eliminated via hepatic metabolism; thus, liver disease may affect its clearance. The pharmacokinetics of ondansetron in patients with different degrees of hepatic insufficiency (N = 12 with hepatic impairment, as categorized by Pugh's classification method) were assessed and the results compared with results for age- and gender-matched control subjects with normal liver function (n = 12). A secondary objective was to correlate the Pugh method of assessing hepatic impairment and quantitative metabolic markers used to assess hepatic function (antipyrine clearance and indocyanine green clearance) with changes in the pharmacokinetics of ondansetron. This was an open-label study in which 8 mg ondansetron was given orally and intravenously, following a randomized crossover design. Clearance of ondansetron was lower among patients with hepatic impairment than control subjects. After a single, oral dose of ondansetron, mean absolute bioavailability increased markedly with increased hepatic insufficiency (approaching 100% in the group with severe hepatic impairment versus 66% for control subjects). These data suggest that there is a reduced first-pass effect in patients with liver disease resulting in a higher AUC0-∞. A correlation existed between clearance of ondansetron and decreased antipyrine clearance; a smaller correlation existed between ondansetron clearance and indocyanine green clearance. Mean percent of ondansetron bound to plasma proteins was significantly lower in patients with liver disease than in control subjects. None of the patients experienced any severe adverse reactions attributed to ondansetron. A reduction in the clearance of ondansetron is associated with increasing degrees of hepatic insufficiency; therefore, patients with severe hepatic impairment (Pugh score of>9) should have their daily dose of ondansetron limited to 8 mg (or 0.15 mg/kg)." @default.
• W2023694826 created "2016-06-24" @default.
• W2023694826 creator A5001321994 @default.
• W2023694826 creator A5011496181 @default.
• W2023694826 creator A5023435347 @default.
• W2023694826 creator A5029383123 @default.
• W2023694826 creator A5044340641 @default.
• W2023694826 creator A5052392053 @default.
• W2023694826 creator A5060601295 @default.
• W2023694826 creator A5073877566 @default.
• W2023694826 creator A5086326839 @default.
• W2023694826 date "1996-03-01" @default.
• W2023694826 modified "2023-10-06" @default.
• W2023694826 title "Pharmacokinetics of Ondansetron in Patients with Hepatic Insufficiency" @default.
• W2023694826 cites W1971293066 @default.
• W2023694826 cites W1974912928 @default.
• W2023694826 cites W1997364324 @default.
• W2023694826 cites W2021664900 @default.
• W2023694826 cites W2046256234 @default.
• W2023694826 cites W2060123467 @default.
• W2023694826 cites W2069009402 @default.
• W2023694826 cites W2131314440 @default.
• W2023694826 cites W2341319633 @default.
• W2023694826 cites W2416488019 @default.
• W2023694826 cites W4240546462 @default.
• W2023694826 cites W74649421 @default.
• W2023694826 doi "https://doi.org/10.1002/j.1552-4604.1996.tb04190.x" @default.
• W2023694826 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8690814" @default.
• W2023694826 hasPublicationYear "1996" @default.
• W2023694826 type Work @default.
• W2023694826 sameAs 2023694826 @default.
• W2023694826 citedByCount "42" @default.
• W2023694826 countsByYear W20236948262012 @default.
• W2023694826 countsByYear W20236948262013 @default.
• W2023694826 countsByYear W20236948262014 @default.
• W2023694826 countsByYear W20236948262015 @default.
• W2023694826 countsByYear W20236948262016 @default.
• W2023694826 countsByYear W20236948262017 @default.
• W2023694826 countsByYear W20236948262018 @default.
• W2023694826 countsByYear W20236948262019 @default.
• W2023694826 countsByYear W20236948262022 @default.
• W2023694826 countsByYear W20236948262023 @default.
• W2023694826 crossrefType "journal-article" @default.
• W2023694826 hasAuthorship W2023694826A5001321994 @default.
• W2023694826 hasAuthorship W2023694826A5011496181 @default.
• W2023694826 hasAuthorship W2023694826A5023435347 @default.
• W2023694826 hasAuthorship W2023694826A5029383123 @default.
• W2023694826 hasAuthorship W2023694826A5044340641 @default.
• W2023694826 hasAuthorship W2023694826A5052392053 @default.
• W2023694826 hasAuthorship W2023694826A5060601295 @default.
• W2023694826 hasAuthorship W2023694826A5073877566 @default.
• W2023694826 hasAuthorship W2023694826A5086326839 @default.
• W2023694826 hasConcept C112705442 @default.
• W2023694826 hasConcept C126322002 @default.
• W2023694826 hasConcept C141071460 @default.
• W2023694826 hasConcept C197934379 @default.
• W2023694826 hasConcept C201253974 @default.
• W2023694826 hasConcept C2777075537 @default.
• W2023694826 hasConcept C2777170512 @default.
• W2023694826 hasConcept C2777214474 @default.
• W2023694826 hasConcept C2779102576 @default.
• W2023694826 hasConcept C2780580376 @default.
• W2023694826 hasConcept C2781065829 @default.
• W2023694826 hasConcept C2992208098 @default.
• W2023694826 hasConcept C2994203108 @default.
• W2023694826 hasConcept C42219234 @default.
• W2023694826 hasConcept C512861765 @default.
• W2023694826 hasConcept C71924100 @default.
• W2023694826 hasConcept C90924648 @default.
• W2023694826 hasConceptScore W2023694826C112705442 @default.
• W2023694826 hasConceptScore W2023694826C126322002 @default.
• W2023694826 hasConceptScore W2023694826C141071460 @default.
• W2023694826 hasConceptScore W2023694826C197934379 @default.
• W2023694826 hasConceptScore W2023694826C201253974 @default.
• W2023694826 hasConceptScore W2023694826C2777075537 @default.
• W2023694826 hasConceptScore W2023694826C2777170512 @default.
• W2023694826 hasConceptScore W2023694826C2777214474 @default.
• W2023694826 hasConceptScore W2023694826C2779102576 @default.
• W2023694826 hasConceptScore W2023694826C2780580376 @default.
• W2023694826 hasConceptScore W2023694826C2781065829 @default.
• W2023694826 hasConceptScore W2023694826C2992208098 @default.
• W2023694826 hasConceptScore W2023694826C2994203108 @default.
• W2023694826 hasConceptScore W2023694826C42219234 @default.
• W2023694826 hasConceptScore W2023694826C512861765 @default.
• W2023694826 hasConceptScore W2023694826C71924100 @default.
• W2023694826 hasConceptScore W2023694826C90924648 @default.
• W2023694826 hasIssue "3" @default.
• W2023694826 hasLocation W20236948261 @default.
• W2023694826 hasLocation W20236948262 @default.
• W2023694826 hasOpenAccess W2023694826 @default.
• W2023694826 hasPrimaryLocation W20236948261 @default.
• W2023694826 hasRelatedWork W1969748827 @default.
• W2023694826 hasRelatedWork W1998246580 @default.
• W2023694826 hasRelatedWork W2016870681 @default.
• W2023694826 hasRelatedWork W2068801349 @default.
• W2023694826 hasRelatedWork W2369355129 @default.
• W2023694826 hasRelatedWork W2397286692 @default.
• W2023694826 hasRelatedWork W2409484351 @default.

• next